Bipartisan MODERN Labeling Act Included Washington, DC – December 22, 2020 – Friends of Cancer Research (Friends) applauds the bipartisan work of the House and Senate to bolster the U.S. economy and support patients, physicians, and families during the COVID-19 pandemic. We would also like to acknowledge the strong bipartisan work of the Members and…
Washington, DC – December 2, 2020 – Friends of Cancer Research (Friends) praises the scientific endeavor that has unfolded during the past months to discover a safe and effective vaccine against the novel coronavirus (COVID-19). It has been no small feat and could not have been achieved as quickly and safely as it has without…
Washington, DC – Today, the Reagan-Udall Foundation for the FDA, in collaboration with Friends of Cancer Research, announce the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder, collaborative project to leverage real-world data in the diagnostic test (e.g., nucleic acid or antigenic) and antibody test (e.g., serological) study space. Bringing together device manufacturers, technology companies, government and…
Today, Friends of Cancer Research (Friends) released the findings from Phase 2 of its TMB Harmonization Project at the AACR Virtual Annual Meeting I. These results are the outcome of the large-scale project led by Friends, which is leading the standardization of tumor mutational burden (TMB) calculation and reporting, in order to more effectively evaluate…
The Reagan-Udall Foundation for the FDA (Foundation) in collaboration with Friends of Cancer Research (Friends) today announced the COVID-19 Evidence Accelerator, an expansive public-private partnership combining the efforts of academic, government, and private sector organizations applying data analytics to accelerate the understanding of COVID-19. “We are honored to be launching this new initiative, working…
Like millions of our colleagues, friends, and family, Friends of Cancer Research is adjusting to the rapidly changing public health crisis being caused by COVID-19 (Novel Coronavirus). We are steadfast in our commitment to patients and will be working everyday to move our research, scientific programs, and policy solutions forward on their behalf. While…
Friends of Cancer Research (Friends) would like to thank Senators Burr and Bennet and Representatives DeGette and Bucshon for their commitment to patients through the introduction of the Verifying Accurate, Leading‑edge IVCT Development (VALID) Act. By continuing to advance this legislation, which would enable uniform oversight of diagnostics, these members have set a path toward…
Atlanta, GA – January 28, 2020 – A team of leaders in patient advocacy and education at the Black Women’s Health Imperative (BWHI), Friends of Cancer Research (Friends), and Stand Up To Cancer (SU2C) have been approved for a funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the…
Washington, DC – December 12, 2019 – Friends of Cancer Research (Friends) would like to thank the Senate for doing what is right by patients and confirming Dr. Stephen Hahn as FDA commissioner by a vote of 72-18. “The U.S. is at an inflection point for science and innovation,” said Friends’ Chair and Founder Ellen…
Washington, DC – November 20, 2019 – Today, Dr. Stephen Hahn, President Trump’s nominee to be the next Commissioner of the U.S. Food and Drug Administration (FDA), appeared before the Senate Health, Education, Labor and Pension Committee (HELP) and answered wide-ranging questions relating to the many important roles the Commissioner must oversee. “The FDA…
